Synapse

← Iliana Michailidou

Papers by Iliana Michailidou

Page 1 · newest first

  1. Amyotrophic Lateral Sclerosis: Advances in Diagnosis, Pathophysiology, and Emerging Therapeutic Strategies2025
  2. The role of complement in the immunopathogenesis of acetylcholine receptor antibody-positive generalized myasthenia gravis: bystander or key player?Frontiers in Immunology · 2025
  3. The role of amino acid metabolism in neurodegenerative diseasesGene & Protein in Disease · 2024
  4. Neurological Immune-Related Adverse Events Induced by Immune Checkpoint InhibitorsBiomedicines · 2024
  5. PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cellsBrain · 2024
  6. Systemic LPS Administration Stimulates the Activation of Non-Neuronal Cells in an Experimental Model of Spinal Muscular AtrophyCells · 2024
  7. The Time Trajectory of Choroid Plexus Enlargement in Multiple SclerosisHealthcare · 2024
  8. Argininemia: Pathophysiology and Novel Methods for Evaluation of the DiseaseApplied Sciences · 2024
  9. Editorial: Complement in nervous system diseaseFrontiers in Cellular Neuroscience · 2023
  10. Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibodyFrontiers in Cellular Neuroscience · 2023
  11. Defective Schwann cell lipid metabolism alters plasma membrane dynamics in Charcot-Marie-Tooth disease 1A2023
  12. Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interactionFrontiers in Neurology · 2023
  13. The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed PMP22Current Research in Neurobiology · 2023
  14. Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary InjuryNeurotherapeutics · 2022
  15. Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack ComplexJournal of Innate Immunity · 2022
  16. Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosisJCI Insight · 2022
  17. Accumulation of meningeal lymphocytes, but not myeloid cells, correlates with subpial cortical demyelination and white matter lesion activity in progressive MS patients2021
  18. Balloon cells promote immune system activation in focal cortical dysplasia type 2bNeuropathology and Applied Neurobiology · 2021
  19. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegenerationActa Neuropathologica · 2021
  20. Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitisSHILAP Revista de lepidopterología · 2018
  21. Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesisGlia · 2016
  22. Complement is activated in progressive multiple sclerosis cortical grey matter lesionsJournal of Neuroinflammation · 2016
  23. Phenotypic Variation in Aicardi–Goutières Syndrome Explained by Cell-Specific IFN-Stimulated Gene Response and Cytokine ReleaseThe Journal of Immunology · 2015
  24. Complement C1q‐C3–associated synaptic changes in multiple sclerosis hippocampusAnnals of Neurology · 2015
  25. Activation of endogenous neural stem cells for multiple sclerosis therapyFrontiers in Neuroscience · 2015
  26. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesionsGlia · 2014